Cite
MLA Citation
N. W. van de Donk et al.. “S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB.” HemaSphere, vol. 6, n.d., pp. 84–85. http://access.bl.uk/ark:/81055/vdc_100158013909.0x000019